VanEck Australian Floating Rate ETF vs Stryker Corporation — how do they compare? VanEck Australian Floating Rate ETF trades at $50.98, while Stryker Corporation trades at $330.42 (market cap $121.31B). The key difference: Stryker Corporation pays a 1.11% dividend while VanEck Australian Floating Rate ETF pays none, and VanEck Australian Floating Rate ETF is trading nearer its 52-week high, Stryker Corporation nearer its low. Which is the better fit depends on your goals.
| FLOT | SYK | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $51.09 | $403.53 |
52-Week Low | $50.72 | $282.58 |
Market Cap | — | $121.31B |
Enterprise Value | — | $133.07B |
Dividend Yield | — | 1.11% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Stryker (SYK) trades at $330.48, up 6.19% with strong analyst support (74% buy ratings) and a $388.44 consensus price target. The stock shows bearish technical signals despite recent earnings beats in Q3 and Q4 2025, offset by a Q1 2026 miss attributed to a temporary cyber disruption. Fundamentals remain solid with 63.83% gross margins and 13.21% net income margin, while the company continues innovation with Mako robotics expansion and new product launches.
The outlook remains positive given maintained full-year guidance and healthy end-market demand. Key risks include cybersecurity vulnerabilities and competitive pressures, but institutional confidence is high with no sell ratings. The current valuation at 36.63 P/E offers potential upside to the price target, supported by robust cash flow generation and dividend consistency.
Trailing returns across standard periods
Latest headlines on both assets
FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.
Read more on FLOT →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →